Monopar Therapeutics (MNPR) Stock Chart & Stock Price History $39.84 -1.92 (-4.59%) As of 12:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monopar Therapeutics Stock Price Performance The Monopar Therapeutics (MNPR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1,206.07%, with a year-to-date return of 81.07%. In the past month, the stock has increased 11.05%, reflecting recent market activity. As of the latest close, Monopar Therapeutics traded at $41.75 with a market cap of $255.30 million and volume of 28,749 shares. Five years ago, the stock traded at a split-adjusted price of $36.95, representing a 7.81% increase over that period. At the time, it had a market cap of $78.56 million and a volume of 506 shares. Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.27%1 Month Performance+11.05%3 Month Performance-8.13%Year-To-Date Performance+81.07%1 Year Performance+1,206.07%5 Year Performance+7.81% MNPR Stock Chart for Tuesday, August, 5, 2025 MNPR Chart by TradingView Monopar Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$40.69$41.75+2.61%$42.21$39.9228,749 shs$255.30 million08/01/2025$41.18$40.69-1.19%$41.60$39.6135,807 shs$248.82 million07/31/2025$42.66$41.18-3.47%$42.65$40.719,916 shs$252.02 million07/30/2025$43.03$42.66-0.86%$44.34$41.6713,086 shs$261.08 million07/29/2025$43.40$43.03-0.85%$44.36$41.508,963 shs$263.13 million07/28/2025$44.97$43.40-3.49%$44.58$43.0113,035 shs$265.61 million07/25/2025$46.82$44.97-3.95%$47.00$44.3710,251 shs$275.22 million07/24/2025$46.87$46.82-0.11%$47.52$45.2012,769 shs$286.54 million07/23/2025$45.22$46.87+3.65%$46.91$45.2014,761 shs$286.61 million07/22/2025$46.43$45.22-2.61%$45.54$44.2615,513 shs$276.75 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$46.48$46.43-0.11%$48.35$45.1129,618 shs$284.15 million07/18/2025$47.25$46.48-1.63%$50.14$46.4830,457 shs$284.46 million07/17/2025$41.07$47.25+15.05%$47.28$40.7959,669 shs$289.17 million07/16/2025$39.76$41.07+3.29%$41.07$39.5626,967 shs$251.14 million07/15/2025$43.73$39.76-9.08%$45.00$39.6285,566 shs$243.33 million07/14/2025$36.87$43.73+18.61%$45.50$37.19124,760 shs$267.63 million07/11/2025$38.26$36.87-3.63%$38.25$35.5840,442 shs$225.64 million07/10/2025$40.44$38.26-5.39%$42.00$38.2335,147 shs$233.96 million07/09/2025$38.37$40.44+5.39%$40.47$37.1749,522 shs$247.49 million07/08/2025$37.20$38.37+3.15%$39.62$37.0062,086 shs$234.82 million07/07/2025$35.87$37.20+3.71%$37.78$35.3749,658 shs$227.66 million07/04/2025$35.87$35.87$36.25$34.9124,007 shs$219.52 million Related Companies Arcus Biosciences Stock Price Chart Pharvaris Stock Price Chart Spyre Therapeutics Stock Price Chart Avadel Pharmaceuticals Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Jyong Biotech Stock Price Chart Iovance Biotherapeutics Stock Price Chart Enliven Therapeutics Stock Price Chart Anavex Life Sciences Stock Price Chart Structure Therapeutics Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNPR Stock Alerts